These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 35706696)

  • 1. Comparison of disease prevalence in two populations under double-sampling scheme with two fallible classifiers.
    Qiu SF; He J; Tao JR; Tang ML; Poon WY
    J Appl Stat; 2020; 47(8):1375-1401. PubMed ID: 35706696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Test procedure and sample size determination for a proportion study using a double-sampling scheme with two fallible classifiers.
    Qiu SF; Zeng XS; Tang ML; Poon WY
    Stat Methods Med Res; 2019 Apr; 28(4):1019-1043. PubMed ID: 29233082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interval estimation for a proportion using a double-sampling scheme with two fallible classifiers.
    Qiu SF; Lian H; Zou GY; Zeng XS
    Stat Methods Med Res; 2018 Aug; 27(8):2478-2503. PubMed ID: 27932666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of disease prevalence in two populations in the presence of misclassification.
    Tang ML; Qiu SF; Poon WY
    Biom J; 2012 Nov; 54(6):786-807. PubMed ID: 22941869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Homogeneity testing for binomial proportions under stratified double-sampling scheme with two fallible classifiers.
    Qiu SF; Fu QX
    Stat Methods Med Res; 2020 Dec; 29(12):3547-3568. PubMed ID: 32640937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sample size determination for disease prevalence studies with partially validated data.
    Qiu SF; Poon WY; Tang ML
    Stat Methods Med Res; 2016 Feb; 25(1):37-63. PubMed ID: 22374341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Confidence interval construction for proportion difference from partially validated series with two fallible classifiers.
    Qiu SF; Wang LM; Tang ML; Poon WY
    J Biopharm Stat; 2022 Nov; 32(6):871-896. PubMed ID: 35536693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Test procedures for disease prevalence with partially validated data.
    Tang ML; Qiu SF; Poon WY; Tang NS
    J Biopharm Stat; 2012; 22(2):368-86. PubMed ID: 22251180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A simulation study for comparing testing statistics in response-adaptive randomization.
    Gu X; Lee JJ
    BMC Med Res Methodol; 2010 Jun; 10():48. PubMed ID: 20525382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Classifier design for computer-aided diagnosis: effects of finite sample size on the mean performance of classical and neural network classifiers.
    Chan HP; Sahiner B; Wagner RF; Petrick N
    Med Phys; 1999 Dec; 26(12):2654-68. PubMed ID: 10619251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Confidence intervals for proportion difference from two independent partially validated series.
    Qiu SF; Poon WY; Tang ML
    Stat Methods Med Res; 2016 Oct; 25(5):2250-2273. PubMed ID: 24448443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Testing approaches for overdispersion in poisson regression versus the generalized poisson model.
    Yang Z; Hardin JW; Addy CL; Vuong QH
    Biom J; 2007 Aug; 49(4):565-84. PubMed ID: 17638291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple test procedures of disease prevalence based on stratified partially validated series in the presence of a gold standard.
    Qiu SF; Zhang XL; Qu YQ; Han YQ
    J Biopharm Stat; 2023 Oct; ():1-22. PubMed ID: 37853747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Homogeneity test of rate ratios in stratified matched-pair studies.
    Li HQ; Tang NS
    Biom J; 2011 Jul; 53(4):614-27. PubMed ID: 21608010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypothesis testing and sample size considerations for the test-negative design.
    Huo Y; Yang Y; Halloran ME; Longini IM; Dean NE
    Res Sq; 2023 Dec; ():. PubMed ID: 38234799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Testing the non-unity of rate ratio under inverse sampling.
    Tang ML; Liao YJ; Ng HK; Chan PS
    Biom J; 2007 Aug; 49(4):551-64. PubMed ID: 17621387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of sample size for a multi-class classifier based on single-nucleotide polymorphisms: a volume under the surface approach.
    Liu X; Wang Y; Sriram TN
    BMC Bioinformatics; 2014 Jun; 15():190. PubMed ID: 24930009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimal two-phase sampling for comparing correlated areas under the ROC curves of two screening tests in the presence of verification bias.
    Wu Y
    J Biopharm Stat; 2024 Jun; ():1-17. PubMed ID: 38867658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A general approach to sample size determination for prevalence surveys that use dual test protocols.
    Cheng D; Stamey JD; Branscum AJ
    Biom J; 2007 Aug; 49(5):694-706. PubMed ID: 17722203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Power and sample size calculation incorporating misspecifications of the variance function in comparative clinical trials with over-dispersed count data.
    Igeta M; Takahashi K; Matsui S
    Biometrics; 2018 Dec; 74(4):1459-1467. PubMed ID: 29579337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.